Mirum Pharmaceuticals ^Company

Mirum Pharmaceuticals is dedicated to creating life-changing therapies for patients with liver diseases. The company's pipeline consists of two clinical-stage product candidates with mechanisms of action that have potential utility across a wide range of rare liver diseases. They are advancing lead candidate, maralixibat for Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC) — conditions with a profound and devastating impact on quality of life for young patients...